DVMnews.com reminds us that Pfizer recently donated $1.1 million to the Morris Foundation. The money will be used to establish a national canine tumor biospecimen bank. DVM’s brief article is here. The announcement on the Morris Web site is here.
Catmanager has often felt frustrated by Pfizer’s approach to the veterinary pharmaceutical market; specifically its refusal to sell its human drugs directly to veterinarians (or the main veterinary distributors)—the day a generic form of azithromycin became available was a happy one for our clinic! Nonetheless, their donation is a pretty cool thing. The tumor bank will, I hope, benefit our canine friends for many years to come.